Nanjing Yihua Pharmaceutical

Nanjing Yihua Pharmaceutical is a China-based pharmaceutical company specializing in the development, production, and commercialization of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 2003 as a key manufacturing subsidiary of Nanjing Pharmaceutical Factory, the company is located in the Nanjing Chemical Industrial Park. Its core business focuses on therapeutic areas such as cardiovascular health, metabolic disorders, and anti-infectives, with a portfolio featuring widely used generic medications like Atorvastatin Calcium and Clopidogrel Bisulfate. The company operates state-of-the-art, GMP-certified facilities designed to meet both domestic and international regulatory standards. In addition to its own product line, Nanjing Yihua provides contract development and manufacturing services (CDMO) to global pharmaceutical partners.